Conformational changes at benzodiazepine binding sites of GABA A receptors detected with a novel technique

Benzodiazepines are widely used for their anxiolytic, sedative, myorelaxant and anticonvulsant properties. They allosterically modulate GABA A receptor function by increasing the apparent affinity of the agonist GABA. We studied conformational changes induced by channel agonists at the benzodiazepine binding site. We used the rate of covalent reaction between a benzodiazepine carrying a cysteine reactive moiety with mutated receptor having a cysteine residue in the benzodiazepine binding pocket, α 1 H101Cβ 2 γ 2 , as a sensor of its conformation. This reaction rate is sensitive to local conformational changes. Covalent reaction locks the receptor in the conformation stabilized by positive allosteric modulators. By using concatenated subunits we demonstrated that the covalent reaction occurs either exclusively at the α/γ subunit interface, or if it occurs in both α 1 subunits, exclusively reaction at the α/γ subunit interface can modulate the receptor. We found evidence for an increased rate of reaction of activated receptors, whereas reaction rate with the desensitized state is slowed down. The benzodiazepine antagonist Ro15–1788 efficiently inhibited the covalent reaction in the presence of 100 µ m GABA but only partially in its absence or in the presence of 10 µ m GABA. It is concluded that Ro15–1788 efficiently protects activated and desensitized states, but not the resting state.